Investment Objective: Global X Genomics & Biotechnology ETF is an investment vehicle . It is currently trading at 65.58 USD.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (100%),
the Technology sector (0%)
and markets in
United States (84%),
Netherlands (5%),
Hong Kong (4%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This is a distributing fund with a current yield of 1.31%.
Yes, it pays an annual dividend of 0.60 USD (1.31% yield).
Global X Genomics & Biotechnology ETF is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.65 USD
|
| July 7, 2027 (estimated) | 0.0580 |
| Jan. 7, 2027 (estimated) | 0.5910 |
| ▸2026 |
0.65 USD
|
| July 7, 2026 | 0.0580 |
| Jan. 7, 2026 | 0.5910 |
| ▸2025 |
0.01 USD
|
| July 7, 2025 | 0.0083 |
| ▸2022 |
0.01 USD
|
| Jan. 7, 2022 | 0.0070 |
| ▸2021 |
0.03 USD
|
| Jan. 8, 2021 | 0.0320 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Global X Genomics & Biotechnology ETF | Jul 07, 2026 | Paid | 0.058 USD |
| Global X Genomics & Biotechnology ETF | Jan 07, 2026 | Paid | 0.591 USD |
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 2, 2025 | 1:4 |
Community Discussion